Bangalore, India -- (SBWIRE) -- 01/09/2018 -- Off-pump coronary artery bypass (OPCAB), or simply beating-heart coronary artery bypass grafting, utilizes a medial sternotomy to access the heart, similarly to on-pump coronary artery bypass (ONCAB) procedures. The important difference is that the cardiopulmonary bypass pump is not employed. Clinical studies show that OPCAB offers several benefits compared to ONCAB procedures, including reductions in bleeding, decreases in short-term neurocognitive dysfunction, kidney dysfunction and length of hospital stay. Despite these advantages, the inherent technical challenges of performing OPCAB have impeded its widespread adoption.

These off-pump procedures require special techniques and instrumentation in order to perform efficient and reliable anastomosis on the beating heart. The increasing penetration of anastomosis assist devices (AAD) has helped to create precise and reliable anastomoses and slow the decline in OPCAB procedure volume.

It should be noted that all minimally invasive coronary artery bypass graft (CABG) procedures, including minimally invasive direct coronary artery bypass (MIDCAB) and totally endoscopic coronary artery bypass (TECAB), are performed off-pump. These procedures differ from traditional OPCAB techniques in that they do not require a highly invasive medial sternotomy.

OPCAB procedures are much harder to perform because the beating heart adds difficulty in performing a bypass on the posterior and lateral walls of the heart. Surgeons have found many ways to stabilize the heart to bypass the necessary arteries. Most commonly, stabilizer and positioner devices are used in surgeries to aid physicians in stabilizing and positioning the heart and arteries.

Spanning over 393 pages "US Market Report for Off-Pump Coronary Artery Bypass Devices 2018 - MedCore" report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, Product Portfolio, Off-Pump Coronary Artery Bypass Device Market, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.

For more information Visit at: https://www.drugpipeline.net/idata-research/us-market-report-pump-coronary-artery-bypass-devices-2018-medcore-0

Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare

Related Reports;

US Market Report for Transcatheter Heart Valve Replacement Machines 2018 - MedCore - Visit at - https://www.drugpipeline.net/idata-research/us-market-report-transcatheter-heart-valve-replacement-machines-2018-medcore

US Market Report for On-Pump Coronary Artery Bypass Devices 2018 - MedCore - Visit at - https://www.drugpipeline.net/idata-research/us-market-report-pump-coronary-artery-bypass-devices-2018-medcore

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.